Skip to content
LATEST
Health

European Regulators Recommend Conditional Authorization for Ebola Vaccine

European regulators have recommended conditional authorization for the rVSV-ZEBOV-GP vaccine, though widespread availability is not expected until mid-2020…

European Regulators Recommend Conditional Authorization for Ebola Vaccine

The European Medicines Agency has recommended conditional marketing authorization for the rVSV-ZEBOV-GP Ebola vaccine. This regulatory milestone precedes a final licensing decision by the European Commission and facilitates the World Health Organization’s prequalification process.

Regulatory cooperation between international health bodies and African regulators aims to accelerate vaccine registration in high-risk regions. Despite this progress, licensed doses are not expected to be commercially available until mid-2020. Current vaccination efforts in the Democratic Republic of the Congo will continue under existing research and compassionate use protocols.

Supply constraints remain a significant operational risk. International health organizations are currently developing a global security plan to manage stockpiles and increase manufacturing capacity. Eight additional vaccine candidates are undergoing clinical evaluation to address long-term demand and supply volatility.

More stories

Latest news